» Articles » PMID: 9802753

Erectile Dysfunction in Diabetic Subjects in Italy. Gruppo Italiano Studio Deficit Erettile Nei Diabetici

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 1998 Nov 5
PMID 9802753
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Our objective was to analyze the prevalence and risk factors for erectile dysfunction (ED) in men with diabetes in Italy in a cross-sectional study.

Research Design And Methods: Eligible for the study were men aged 20-69 years with a diagnosis of IDDM or NIDDM who were observed on randomly selected days in 178 diabetes centers in Italy. ED was defined as a failure to achieve and maintain an erection sufficient for satisfactory sexual performance.

Results: Of the 9,868 diabetic men interviewed, 3,534 (35.8%) reported ED. The prevalence increased with age, from 4.6% in men aged 20-29 to 45.5% in those aged > or =60 years (test for trend, P = 0.0001). After taking into account the confounding role of age, men with NIDDM reported ED less frequently than did men with IDDM (odds ratio [OR], 0.7; 95% CI 0.6-0.8). In comparison with men reporting diabetes lasting < or =5 years, the ORs for ED were 1.3 and 2.0 for subjects with diabetes lasting 6-10 and 11-30 years, respectively. In comparison with men with good metabolic control, the ORs for ED were 1.7 and 2.3 in men with fair and poor control, respectively. A history of diabetes-related arterial, retinal, or renal diseases and neuropathy was associated with an increased risk of ED. Finally, in comparison with never-smokers, the ORs for ED were 1.5 (95% CI 1.3-1.6) for current smokers and 1.4 (95% CI 1.3-1.6) for ex-smokers. The OR increased with number of cigarettes smoked per day: in comparison with men smoking <12 cigarettes per day, the OR was 1.5 (95% CI 1.3-1.7) for those smoking > or =30 cigarettes day.

Conclusions: The study offers a quantitative estimate of the prevalence of ED and of its main risk factors in Italian men with diabetes.

Citing Articles

A comprehensive analysis of erectile dysfunction prevalence and the impact of prostate conditions on ED among US adults: evidence from NHANES 2001-2004.

Zhang Y, Zang N, Xiang Y, Lin F, Liu X, Zhang J Front Endocrinol (Lausanne). 2025; 15:1412369.

PMID: 39872316 PMC: 11769807. DOI: 10.3389/fendo.2024.1412369.


Exploring the Molecular Link Between Diabetes and Erectile Dysfunction Through Single-Cell Transcriptome Analysis.

Begum M, Choubey M, Tirumalasetty M, Arbee S, Sadik S, Mohib M Genes (Basel). 2025; 15(12.

PMID: 39766863 PMC: 11675191. DOI: 10.3390/genes15121596.


Sexual dysfunction, depression, and marital adjustment in diabetic male patients.

Rathod A, Sawant N, Bandgar T Indian J Psychiatry. 2024; 66(9):853-858.

PMID: 39502598 PMC: 11534130. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_293_24.


Risk factors for erectile dysfunction in diabetes mellitus: a systematic review and meta-analysis.

Dilixiati D, Waili A, Tuerxunmaimaiti A, Tao L, Zebibula A, Rexiati M Front Endocrinol (Lausanne). 2024; 15:1368079.

PMID: 38638136 PMC: 11024441. DOI: 10.3389/fendo.2024.1368079.


Erectile Dysfunction: Causes, Diagnosis and Treatment: An Update.

Mazzilli F J Clin Med. 2022; 11(21).

PMID: 36362656 PMC: 9657711. DOI: 10.3390/jcm11216429.